MTS Health Partners LP
Peter J. Collum
Peter joined MTS in 2009 and is a Partner on the Life Sciences Investment Banking Advisory team, and has executed over $20 billion in M&A, debt and equity transactions over the course of his career.
During his time at MTS, selected M&A and financing advisory transactions include Horizon Pharma’s $833 million acquisition of Raptor Pharmaceutical, Baxalta’s $900 million acquisition of Oncaspar from Sigma Tau, Madrigal’s merger with Synta, Aprecia’s $50 million private placement and Jazz Pharmaceuticals’ divestiture of its women’s health business to Meda.
Prior to joining MTS Health Partners, Peter was in the Healthcare Investment Banking Group at Bank of America from 2003 to 2009, most recently as a Director, where he focused on life sciences. Prior to Bank of America, Peter was a technical development engineer at Hoffmann-La Roche from 1996 to 2000. Peter has an MBA from the University of Chicago Booth School of Business and a BS from Rutgers University, College of Engineering, where he also played varsity soccer for a top ranked Rutgers Soccer program. Peter lives in Upper Saddle River, NJ with his wife and three children.